Results

 

Factors associated with a higher/lower risk of in-hospital mortality

Associations between patient-, hospital- and treatment-related factors and in-hospital mortality or lung transplantation in patients with IPF.

Image
Fig 4_Judy.PNG

*Compared with pulmonologist.
Analyzed using multivariable logistic regression.

Length of stay in hospital

  • Median (Q1, Q3) length of stay in hospital was 5 (3, 8) days: 7 (4, 13) days for patients who died in hospital and 5 (3, 8) days for patients who did not.

 Factors estimated to increase length of stay in hospital

Analyzed using a generalized linear model with a negative binomial distribution.

 

Readmissions

Factors associated with a higher/lower risk of 90-day readmission

Associations between patient-, hospital- and treatment-related factors and 90-day readmission (to same hospital) in patients with IPF.

Image
Fig 4_Judy.PNG

*Compared with south US region. †Compared with pulmonologist.
Analyzed using multivariable logistic regression.

Header - Navigation Icon
Header - Navigation Icon
 Methods
Header - Navigation Icon
 Conclusions

This study was funded by Boehringer Ingelheim Pharmaceuticals, Inc (BIPI) as a collaboration with the Duke Clinical Research Institute and Premier, Inc.